ftInvstr
NGLFINE · Healthcare ₹2926.0 +1.66% Mkt Cap ₹1820 Cr

NGLFINE

Healthcare Drug Manufacturers - General
₹2926.0
+1.66% today · 30d +0.9%
as of 2026-11-09
Price · Daily Candles
AI narrative is temporarily unavailable for NGLFINE. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹139 Cr
+33.57% YoY
NET PROFIT
₹18 Cr
+99.09% YoY
OPM
20.95%
+5.28pp YoY
EPS
₹29.78
PE 31.7
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-2.6% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
NGLFINE31.79.0
GLAXO40.0557.97
RUBICON90.2127.36
PFIZER20.9324.29
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
68
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 100
Valuation FAIR 40
Growth STRONG 79
Profitability DECENT 68
Technicals WEAK 40
Risk LOW 80
Key Stats
TTM PE
31.7
P/B
5.51
52W HIGH
₹3602.0
OFF HIGH
-18.77%
DIV YIELD
0.06%
MKT CAP
₹1820 Cr
◉ Active Signals
MACDNeutral39.6344
RSI(14)Bullish61.62
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold NGLFINE and at what entry.

Sign up freeSign in